KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV)
CUSIP: 483497103
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 50,580,036
- Total 13F shares
- 24,320,398
- Share change
- +620,320
- Total reported value
- $582,722,986
- Put/Call ratio
- 154%
- Price per share
- $23.96
- Number of holders
- 108
- Value change
- +$12,095,008
- Number of buys
- 54
- Number of sells
- 63
Quarterly Holders Quick Answers
What is CUSIP 483497103?
CUSIP 483497103 identifies KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 483497103:
Top shareholders of KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Vivo Capital, LLC |
13F
|
Company |
3.7%
|
1,863,296
|
$47,868,000 | — | 31 Mar 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.1%
|
1,559,488
|
$40,062,000 | — | 31 Mar 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3%
|
1,509,025
|
$38,767,000 | — | 31 Mar 2021 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
2.7%
|
1,373,000
|
$35,272,000 | — | 31 Mar 2021 | |
| FMR LLC |
13F
|
Company |
2.7%
|
1,347,970
|
$34,630,000 | — | 31 Mar 2021 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
2.5%
|
1,287,661
|
$33,080,000 | — | 31 Mar 2021 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
2.2%
|
1,133,772
|
$29,117,000 | — | 31 Mar 2021 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
2%
|
1,020,005
|
$26,204,000 | — | 31 Mar 2021 | |
| Polar Capital Holdings Plc |
13F
|
Company |
2%
|
1,007,055
|
$25,871,000 | — | 31 Mar 2021 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
959,892
|
$24,660,000 | — | 31 Mar 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.8%
|
929,481
|
$23,878,000 | — | 31 Mar 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.6%
|
805,000
|
$20,680,000 | — | 31 Mar 2021 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1.5%
|
750,000
|
$19,268,000 | — | 31 Mar 2021 | |
| Nicholas Investment Partners, LP |
13F
|
Company |
1.2%
|
594,130
|
$15,263,000 | — | 31 Mar 2021 | |
| STATE STREET CORP |
13F
|
Company |
1.2%
|
591,472
|
$15,195,000 | — | 31 Mar 2021 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
1.1%
|
565,729
|
$14,534,000 | — | 31 Mar 2021 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
0.83%
|
422,310
|
$10,849,000 | — | 31 Mar 2021 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
0.82%
|
416,212
|
$10,692,000 | — | 31 Mar 2021 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
0.79%
|
397,283
|
$10,206,000 | — | 31 Mar 2021 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.69%
|
350,000
|
$8,992,000 | — | 31 Mar 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.65%
|
327,267
|
$8,407,000 | — | 31 Mar 2021 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.59%
|
296,965
|
$7,629,000 | — | 31 Mar 2021 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.51%
|
258,880
|
$6,651,000 | — | 31 Mar 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.45%
|
228,670
|
$5,875,000 | — | 31 Mar 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.45%
|
228,625
|
$5,873,000 | — | 31 Mar 2021 | |
| Woodline Partners LP |
13F
|
Company |
0.44%
|
224,059
|
$5,756,000 | — | 31 Mar 2021 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.43%
|
218,163
|
$5,605,000 | — | 31 Mar 2021 | |
| Commodore Capital LP |
13F
|
Company |
0.42%
|
214,467
|
$5,510,000 | — | 31 Mar 2021 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.42%
|
214,533
|
$5,486,000 | — | 31 Mar 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.3%
|
153,428
|
$3,942,000 | — | 31 Mar 2021 | |
| Altium Capital Management LLC |
13F
|
Company |
0.25%
|
128,130
|
$3,292,000 | — | 31 Mar 2021 | |
| Laurion Capital Management LP |
13F
|
Company |
0.24%
|
120,000
|
$3,083,000 | — | 31 Mar 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.22%
|
110,504
|
$2,839,000 | — | 31 Mar 2021 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.21%
|
106,777
|
$2,743,000 | — | 31 Mar 2021 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.2%
|
100,000
|
$2,569,000 | — | 31 Mar 2021 | |
| Marshall Wace North America L.P. |
13F
|
Company |
0.19%
|
98,178
|
$2,523,000 | — | 31 Mar 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.16%
|
80,673
|
$2,072,000 | — | 31 Mar 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.13%
|
66,020
|
$1,696,000 | — | 31 Mar 2021 | |
| Global IMC LLC |
13F
|
Company |
0.13%
|
64,603
|
$1,660,000 | — | 31 Mar 2021 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.12%
|
58,600
|
$1,505,000 | — | 31 Mar 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.11%
|
54,599
|
$1,403,000 | — | 31 Mar 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.16%
|
83,090
|
$1,297,000 | — | 31 Mar 2021 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.1%
|
50,244
|
$1,291,000 | — | 31 Mar 2021 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.1%
|
50,000
|
$1,285,000 | — | 31 Mar 2021 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.1%
|
50,000
|
$1,285,000 | — | 31 Mar 2021 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.09%
|
47,681
|
$1,225,000 | — | 31 Mar 2021 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.09%
|
47,116
|
$1,210,000 | — | 31 Mar 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.09%
|
46,897
|
$1,205,000 | — | 31 Mar 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.09%
|
45,411
|
$1,167,000 | — | 31 Mar 2021 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.08%
|
40,567
|
$1,042,000 | — | 31 Mar 2021 |
Institutional Holders of KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) as of Q2 2021
As of 30 Jun 2021,
KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) was held by
108 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,320,398 shares.
The largest 10 holders included
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), RA CAPITAL MANAGEMENT, L.P., Vivo Capital, LLC, WELLINGTON MANAGEMENT GROUP LLP, FRANKLIN RESOURCES INC, BlackRock Inc., STATE STREET CORP, SUVRETTA CAPITAL MANAGEMENT, LLC, JANUS HENDERSON GROUP PLC, and FMR LLC.
This page lists
108
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
115
Q2 2021 holders
108
Holder diff
-7
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.